ZEMURON
ROCURONIUM BROMIDE
Approval overview ZEMURON is listed in Drugs@FDA under application 020214 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ROCURONIUM BROMIDE Form and strength INJECTABLE;INJECTION - 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORGANON USA INC Submission history Latest submission status date: 2018-07-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZEMURON is listed in Drugs@FDA under application 020214 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ROCURONIUM BROMIDE Form and strength INJECTABLE;INJECTION - 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORGANON USA INC Submission history Latest submission status date: 2018-07-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.